DR. MAREN THERESA SCHEUNER, MD, MPH
Medical Practice in Los Angeles, CA
License number
California G068212
Category
Medical Practice
Type
Clinical Genetics (M.D.)
Address
Address
2
8700 Beverly Blvd., Los Angeles, CA 90048
555 36Th St, Manhattan Beach, CA 90266
555 36Th St, Manhattan Beach, CA 90266
Phone
(310) 423-6451
(310) 545-2564
(310) 545-2564
Personal information
See more information about MAREN THERESA SCHEUNER at radaris.comName
Address
Phone
555 36Th St, Manhattan Bch, CA 90266
555 36Th St, Manhattan Beach, CA 90266
555 36Th St, Manhattan Bch, CA 90266
653 36Th St, Manhattan Beach, CA 90266
Professional information
Chief, Division Of Medical Genetics, Va Greater Los Angeles Healthcare System
Position:
Chief, Division of Medical Genetics at Department of Veterans Affairs
Location:
Los Angeles, California
Industry:
Government Administration
Work:
Department of Veterans Affairs
- VA Greater Los Angeles Healthcare System since May 2012
-
Chief, Division of Medical Genetics
Education:
UCLA School of Medicine 1988
MD, Doctor of Medicine
MD, Doctor of Medicine
Dr. Maren T Scheuner, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine, Clinical Genetics
Address:
8700 Beverly Blvd, Los Angeles 90048
(310) 423-6451 (Phone)
VA MEDICAL CTR, EPILEPSY CTR
11301 Wilshire Blvd SUITE 500, Los Angeles 90073
(310) 268-3127 (Phone), (310) 268-4937 (Fax)
(310) 423-6451 (Phone)
VA MEDICAL CTR, EPILEPSY CTR
11301 Wilshire Blvd SUITE 500, Los Angeles 90073
(310) 268-3127 (Phone), (310) 268-4937 (Fax)
Certifications:
Clinical Genetics, 2004, Internal Medicine, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
8700 Beverly Blvd, Los Angeles 90048
VA MEDICAL CTR, EPILEPSY CTR
11301 Wilshire Blvd SUITE 500, Los Angeles 90073
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
VA MEDICAL CTR, EPILEPSY CTR
11301 Wilshire Blvd SUITE 500, Los Angeles 90073
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Education:
Medical School
University of California At Los Angeles
Graduated: 1988
Vet Affairs Med Center
University of California At Los Angeles
Graduated: 1988
Vet Affairs Med Center
Maren Theresa Scheuner M.P.H., Los Angeles CA
Specialties:
Internal Medicine, Medical Genetics, Clinical Genetics, M.D., Pediatric Medical Genetics
Work:
Va Greater Los Angeles Healthcare System
11301 Wilshire Blvd, Los Angeles, CA 90073
11301 Wilshire Blvd, Los Angeles, CA 90073
Education:
University of California at Los Angeles (1988)
Genetic Test To Determine Non-Responsiveness To Statin Drug Treatment
US Patent:
2002010, Aug 8, 2002
Filed:
Jul 3, 2001
Appl. No.:
09/898779
Inventors:
Kent Taylor - Santa Paula CA, US
Maren Scheuner - Manhattan Beach CA, US
Jerome Rotter - Los Angeles CA, US
Huiying Yang - Cerritos CA, US
Maren Scheuner - Manhattan Beach CA, US
Jerome Rotter - Los Angeles CA, US
Huiying Yang - Cerritos CA, US
International Classification:
C12Q001/68, C07H021/04, C12P019/34, C07H021/02
US Classification:
435/006000, 435/091100, 435/091200, 536/024300, 536/023100
Abstract:
In a method for detecting a genetic predisposition in a human for non-responsiveness to statin drug treatment for coronary artery disease, nucleic acids comprising nucleotide sequences of the human lipoprotein lipase (LPL) gene are amplified and analyzed. Homozygosity for a variant allele in a non-coding or untranslated region of the 3′ end of LPL, for example, LPL HindIII 2/2 or (TTTA)4/4 genotypes, is linked to non-responsiveness to treatment with statin drugs, including lovastatin, pravastatin, simvastatin, atorvastatin, fluvastatin, or cerivastatin. Oligonucleotide primer sequences, primer sets, and genetic testing kits allow the practitioner to practice the method and thus better individualize the treatment and improve the care of patients with coronary artery disease.
Personal Assessment Including Familial Risk Analysis For Personalized Disease Prevention Plan
US Patent:
2009001, Jan 15, 2009
Filed:
Feb 2, 2006
Appl. No.:
11/815445
Inventors:
Paula W. Yoon - Norcross GA, US
Maren T. Scheuner - Manhattan Beach CA, US
Cynthia Jorgensen - Atlanta GA, US
Muin J. Khoury - Atlanta GA, US
Maren T. Scheuner - Manhattan Beach CA, US
Cynthia Jorgensen - Atlanta GA, US
Muin J. Khoury - Atlanta GA, US
International Classification:
G06Q 50/00
US Classification:
705 2
Abstract:
Family health history information can be used to assess familial risk for common diseases and determine early detection and prevention medical strategies. Assessed familial risk of disease can then be used to determine recommendations for disease prevention and screening that are targeted to familial risk. Other factors can be included to generate personalized disease prevention recommendations. For example, personal health history information, personal health behavior information, or both can be collected and assessed to generate personalized disease prevention recommendations based on the information collected. Recommendations for disease prevention and screening based at least on familial risk can be used to provide a personalized disease prevention plan that encourages a person to make behavior changes that will reduce the risk of disease and utilize preventive health services.
Genetic Test To Determine Non-Responsiveness To Statin Drug Treatment
US Patent:
6297014, Oct 2, 2001
Filed:
Jul 2, 1999
Appl. No.:
9/347114
Inventors:
Kent D. Taylor - Santa Paula CA
Maren T. Scheuner - Manhattan Beach CA
Jerome I. Rotter - Los Angeles CA
Huiying Yang - Cerritos CA
Maren T. Scheuner - Manhattan Beach CA
Jerome I. Rotter - Los Angeles CA
Huiying Yang - Cerritos CA
Assignee:
Cedars-Sinai Medical Center - Los Angeles CA
International Classification:
C12Q 168, C07H 2104
US Classification:
435 6
Abstract:
In a method for detecting a genetic predisposition in a human for non-responsiveness to statin drug treatment for coronary artery disease, nucleic acids comprising nucleotide sequences of the human lipoprotein lipase (LPL) gene are amplified and analyzed. Homozygosity for a variant allele in a non-coding or untranslated region of the 3' end of LPL, for example, LPL HindIII 2/2 or (TTTA). sub. n 4/4 genotypes, is linked to non-responsiveness to treatment with statin drugs, including lovastatin, pravastatin, simvastatin, atorvastatin, fluvastatin, or cerivastatin. Oligonucleotide primer sequences, primer sets, and genetic testing kits allow the practitioner to practice the method and thus better individualize the treatment and improve the care of patients with coronary artery disease.
Method And Apparatus For Determining Familial Risk Of Disease
US Patent:
8357089, Jan 22, 2013
Filed:
Apr 27, 2011
Appl. No.:
13/095513
Inventors:
Maren Theresa Scheuner - Manhattan Beach CA, US
International Classification:
A61B 5/00
US Classification:
600300, 705 3, 128920, 128923
Abstract:
Personal and family health history information can be used to assess familial risk of disease. For example, information can be collected about the disease history of a person and the person's first- and second-degree relatives and then analyzed to determine the familial risk of common diseases such as coronary heart disease, stroke, type 2 diabetes, and colorectal, breast, and ovarian cancer. Assessed familial risk of disease can then be used by researchers to better estimate the contribution of personal history and family history to the etiology and natural history of a disease of interest, and by consumers and health professionals to determine recommendations for disease management, prevention and screening that are personalized and targeted to the familial risk. Other embodiments are also described and claimed.
Lipoprotein Lipase And Its Effect On Statin Treatments
US Patent:
2010013, May 27, 2010
Filed:
Mar 28, 2008
Appl. No.:
12/594143
Inventors:
Mark O. Goodarzi - Los Angeles CA, US
Kent D. Taylor - Ventura CA, US
Maren T. Scheuner - Manhattan Beach CA, US
Xiuqing Guo - Santa Monica CA, US
Prediman K. Shah - Los Angeles CA, US
Jerome I. Rotter - Los Angeles CA, US
Kent D. Taylor - Ventura CA, US
Maren T. Scheuner - Manhattan Beach CA, US
Xiuqing Guo - Santa Monica CA, US
Prediman K. Shah - Los Angeles CA, US
Jerome I. Rotter - Los Angeles CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
C12Q 1/68, A61K 31/366
US Classification:
514460, 435 6
Abstract:
The invention provides methods of treating and prognosing atherosclerosis and lipid response to statin treatment by determining the presence or absence of haplotypes at the lipoprotein lipase locus. In one embodiment, the invention is practiced by evaluating the prognosis of vascular grafts in an individual undergoing statin treatment by determining the presence or absence of haplotypes at the lipoprotein locus.
Method And Apparatus For Determining Familial Risk Of Disease
US Patent:
7951078, May 31, 2011
Filed:
Feb 1, 2006
Appl. No.:
11/345862
Inventors:
Maren Theresa Scheuner - Manhattan Beach CA, US
International Classification:
A61B 5/00
US Classification:
600300, 705 3, 34053912, 128920, 128923
Abstract:
Personal and family health history information can be used to assess familial risk of disease. For example, information can be collected about the disease history of a person and the person's first- and second-degree relatives and then analyzed to determine the familial risk of common diseases such as coronary heart disease, stroke, type 2 diabetes, and colorectal, breast, and ovarian cancer. Assessed familial risk of disease can then be used by researchers to better estimate the contribution of personal history and family history to the etiology and natural history of a disease of interest, and by consumers and health professionals to determine recommendations for disease management, prevention and screening that are personalized and targeted to the familial risk. Other embodiments are also described and claimed.